Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-01 5:06 pm Unchanged |
2023-01-31 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
0 (Unchanged) |
Filing History |
| 2022-12-29 4:41 pm Purchase |
2022-12-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
PFIZER INC PFE |
5,376,344 12.000% |
5,376,344 (New Position) |
Filing History |
| 2022-07-27 4:42 pm Purchase |
2022-07-17 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
2,955,063,626 (New Position) |
Filing History |
| 2022-06-29 5:09 pm Purchase |
2022-06-22 | 13G | Valneva SE VALN |
PFIZER INC PFE |
9,549,761 8.100% |
9,549,761 (New Position) |
Filing History |
| 2022-06-28 4:19 pm Purchase |
2022-06-17 | 13G | Akero Therapeutics, Inc. AKRO |
PFIZER INC PFE |
2,525,252 6.700% |
2,525,252 (New Position) |
Filing History |
| 2022-04-07 4:51 pm Unchanged |
2022-03-31 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 18.500% |
0 (Unchanged) |
Filing History |
| 2022-04-07 4:11 pm Unchanged |
2022-03-31 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 15.400% |
0 (Unchanged) |
Filing History |
| 2022-03-21 4:25 pm Purchase |
2022-03-11 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
3,978,540 23.100% |
3,978,540 (New Position) |
Filing History |
| 2022-02-14 4:04 pm Purchase |
2021-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR |
PFIZER INC PFE |
89,754 5.560% |
89,754 (New Position) |
Filing History |
| 2022-02-14 12:06 pm Purchase |
2021-12-31 | 13G | Pfizer Inc. PFE |
STATE STREET CORP STT |
285,771,591 5.090% |
5,940,218 (+2.12%) |
Filing History |
| 2022-02-11 7:01 pm Sale |
2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
PFIZER INC PFE |
2,340,330 4.750% |
-2,242,717 (-48.94%) |
Filing History |
| 2022-02-11 6:06 pm Sale |
2021-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
PFIZER INC PFE |
600,000 2.010% |
-1,456,377 (-70.82%) |
Filing History |
| 2022-02-11 5:32 pm Unchanged |
2021-12-31 | 13G | ContraFect Corporation CFRX |
PFIZER INC PFE |
22,316 4.540% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:10 pm Unchanged |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFIZER INC PFE |
1,675,000 3.810% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:55 pm Sale |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
PFIZER INC PFE |
1,372,052 3.880% |
-866,038 (-38.70%) |
Filing History |
| 2022-02-11 4:26 pm Purchase |
2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
PFIZER INC PFE |
2,991,522 9.130% |
2,991,522 (New Position) |
Filing History |
| 2022-02-11 4:06 pm Unchanged |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
PFIZER INC PFE |
1,875,000 3.190% |
0 (Unchanged) |
Filing History |
| 2022-02-11 3:54 pm Sale |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
PFIZER INC PFE |
341,658 1.060% |
-1,325,000 (-79.50%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Pfizer Inc. PFE |
The Vanguard Group | 465,274,925 8.290% |
17,316,178 (+3.87%) |
Filing History |
| 2022-01-31 5:59 pm Purchase |
2021-12-31 | 13G | Pfizer Inc. PFE |
BLACKROCK INC BLK |
409,985,645 7.300% |
13,012,133 (+3.28%) |
Filing History |